Fen Liu
Impact in
- Cancer Research top 5%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
-
- Antiplatelet Therapy and Cardiovascular Diseases
Papers in
-
- Metabolism, Diabetes, and Cancer 5
- RNA modifications and cancer 5
- Amyloidosis: Diagnosis, Treatment, Outcomes 5
- Co-authors
- Yi‐Ning Yang (57 shared papers)Bang‐Dang Chen (60 shared papers)Xiao‐Mei Li (53 shared papers)Zhen-Yan Fu (42 shared papers)Xiang Xie (42 shared papers)Xiang Ma (37 shared papers)Yi-Tong Ma (19 shared papers)Ying‐Ying Zheng (20 shared papers)
- Journals
- PLoS ONE (14 papers)Lipids in Health and Disease (12 papers)Oncotarget (5 papers)Scientific Reports (5 papers)BMC Cardiovascular Disorders (4 papers)
- Partner nations
- ChinaUnited StatesAustralia
In The Last Decade
Fen Liu
181 papers receiving 3.2k citations
Fen Liu's Hit Papers
Peers
Comparison fields: 5 of 155
- Cancer Research 272
- Cardiology and Cardiovascular Medicine 334
- Molecular Biology 1.1k
- Endocrinology, Diabetes and Metabolism 229
- Immunology 233
Countries citing papers authored by Fen Liu
This map shows the geographic impact of Fen Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fen Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fen Liu more than expected).
Fields of papers citing papers by Fen Liu
This network shows the impact of papers produced by Fen Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fen Liu. The network helps show where Fen Liu may publish in the future.
Co-authors
The 25 scholars most cited alongside Fen Liu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 189 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 177 | |
| 2 | 2021 | 142 | |
| 3 | Impact of plant growth-promoting rhizobacteria (PGPR) on plant nutrition and root characteristics: Current perspective Hit paper breakdown → | 2023 | 139 |
| 4 | 2003 | 93 | |
| 5 | 2013 | 89 | |
| 6 | 2014 | 85 | |
| 7 | 2009 | 84 | |
| 8 | 2010 | 75 | |
| 9 | 2013 | 68 | |
| 10 | 2021 | 66 | |
| 11 | 2009 | 64 | |
| 12 | 2017 | 53 | |
| 13 | 2016 | 48 | |
| 14 | 2015 | 42 | |
| 15 | 2018 | 42 | |
| 16 | 2013 | 42 | |
| 17 | 2012 | 39 | |
| 18 | 2017 | 38 | |
| 19 | 2021 | 38 | |
| 20 | 2020 | 38 |
About Fen Liu
Fen Liu is a scholar working on Molecular Biology, Cardiology and Cardiovascular Medicine, Oncology, Surgery and Endocrinology, Diabetes and Metabolism, having authored 189 papers that have together received 3.3k indexed citations. Recurring topics across this work include Diabetes, Cardiovascular Risks, and Lipoproteins (8 papers), Metabolism, Diabetes, and Cancer (5 papers), RNA modifications and cancer (5 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (5 papers), Metal-Organic Frameworks: Synthesis and Applications (4 papers), Autophagy in Disease and Therapy (4 papers), Cancer Immunotherapy and Biomarkers (4 papers) and Lipoproteins and Cardiovascular Health (4 papers). The work is most often cited by research in Cancer Research (272 citations), Cardiology and Cardiovascular Medicine (334 citations), Molecular Biology (1.1k citations), Endocrinology, Diabetes and Metabolism (229 citations) and Immunology (233 citations). Fen Liu has collaborated with scholars based in China, United States and Australia. Frequent co-authors include Yi‐Ning Yang, Bang‐Dang Chen, Xiao‐Mei Li, Zhen-Yan Fu, Xiang Xie, Xiang Ma, Yi-Tong Ma, Ying‐Ying Zheng, Yitong Ma and Zongcheng Yang. Their work appears in journals such as PLoS ONE, Lipids in Health and Disease, Oncotarget, Scientific Reports and BMC Cardiovascular Disorders.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.